chrisvoncsefalvay/vaers-outcomes huggingface dataset:
swelling of gums and lips; swelling of gums and lips; felt fatigue; pain at the injection site (on and off for the next couple of weeks); This spontaneous case was reported by a consumer and describes the occurrence of GINGIVAL SWELLING (swelling of gums and lips), LIP SWELLING (swelling of gums and lips), FATIGUE (felt fatigue) and VACCINATION SITE PAIN (pain at the injection site (on and off for the next couple of weeks)) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy. Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Seasonal allergy.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced GINGIVAL SWELLING (swelling of gums and lips), LIP SWELLING (swelling of gums and lips), FATIGUE (felt fatigue) and VACCINATION SITE PAIN (pain at the injection site (on and off for the next couple of weeks)). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, GINGIVAL SWELLING (swelling of gums and lips), LIP SWELLING (swelling of gums and lips) and FATIGUE (felt fatigue) had resolved and VACCINATION SITE PAIN (pain at the injection site (on and off for the next couple of weeks)) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
On 11/07/2022, at approximately 11:00 AM, he was sneezing a lot, then his head felt stuffed up. He had a headache and neck pain. The back of his knees ached. Each day he felt congested and stuffy. He said he felt he needed to be tested for COVID-19. The home test was negative. He went to see the doctor and was not prescribed anything. He called the doctor back and she prescribed a MEDROL DOSEPAK.
March 10, 2021 I all of a sudden developed inflammation lower back and upper neck at the same time. Medicine has been taken and it still has not went away.
Vaccine administered 3-3-09, on 3-4-09 Pt experienced redness and pain around the injection. Denies itching, or fever. Redness is about size of 50 cent piece.
Chills,upset stomach, head ache, eye ache, elevated temperature, whole body ache.
Pt reported developing a rash 2 days after vaccine administration, as well as swelling on the inner upper left arm. Recommended that pt take OTC BENADRYL for the rash, & to contact PCP if swelling doesn't resolve by the following day.
Initial case received from a consumer, who is also the patient's parent on 18 November 2009. A female patient received an influenza vaccine (manufacturer reported as sanofi pasteur, lot number 78990, which is not a valid sanofi pasteur lot number). She subsequently experienced an itchy arm and throat lasting three hours after vaccination, and red marks on her chest for an unknown period of time. No additional information was provided.
I think I got the long haul covid. I have headaches and I never had headaches before and shoulder pain also neck pain. I have tingling in my feet. Upper right quadrant pain. I'm still hacking up phlegm. I'm in contact with my PCM and she is saying it is probably gonna be long haul covid. When I bend down I feel like I'm gonna feint. I had a telecom meeting with her twice. She just did some kind of procedure where they take my blood pressure from my legs and arms to make sure there are no blood clots. That appointment was 02/24/2022.
rash; Pruritic with erythematous fluid filled vesicle on right 4th digit; erythematous papules and vesicles on left side of shin, right cheek, and right side of chest; erythematous fluid filled vesicle on right 4th digit/vesicles on left side of shin, right cheek and right side of chest; erythematous papules; This non-serious case was reported by a nurse via sales rep and described the occurrence of rash in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 16-AUG-2023, the patient received the 1st dose of Shingrix. In AUG-2023, less than a week after receiving Shingrix, the patient experienced pruritus (Verbatim: Pruritic with erythematous fluid filled vesicle on right 4th digit), papule (Verbatim: erythematous papules and vesicles on left side of shin, right cheek, and right side of chest), vesicles (Verbatim: erythematous fluid filled vesicle on right 4th digit/vesicles on left side of shin, right cheek and right side of chest) and erythema (Verbatim: erythematous papules ). On 17-AUG-2023, the patient experienced rash (Verbatim: rash).  The outcome of the rash, pruritus, papule, vesicles and erythema were not reported.   It was unknown if the reporter considered the rash, pruritus, papule, vesicles and erythema to be related to Shingrix.     It was unknown if the company considered the rash, pruritus, papule, vesicles and erythema to be related to Shingrix.   Additional Information: GSK receipt date: 21-Aug-2023 The patient received a dose of Shingirx at 8:30 am at local pharmacy (not in office).  The patient woke up next day of vaccination, with rash.  In August 2023, less than a week, pruritic with erythematous fluid filled vesicle on right 4th digit, erythematous papules and vesicles on left side of shin, right cheek, and right side of chest. Dose information was not given to the office. The reporter consented to follow-up.
Panic attack approximately 6-7 hours after shot. Quick pain in chest, shallow breathing, asphyxia, panic.
pt recvd vax & devel pain @ the inject site; No further details were provided;
This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), PYREXIA (low grade fever) and MYALGIA (body aches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COUGH (cough), PYREXIA (low grade fever) and MYALGIA (body aches). At the time of the report, COUGH (cough), PYREXIA (low grade fever) and MYALGIA (body aches) outcome was unknown. No Concomitant medications were reported. No treatment medications were reported.
On Wednesday night through Thursday morning (the 22nd - 23rd), I started developing rashes all over my body. I also had a fast heart beat during this time. When they started getting a bit 'harder' and raised, I realised I was dealing with hives. They covered almost every single body part and the coming days they just kept appearing on different spots all over my body, including my face. Every time the hives were close to a joint, I also have joint pain. For instance, when it was on my thumb, I had difficulty bending my thumb. Also, when the hives were all over my chin and jawline, I stated getting toothache, even though I haven't had a cavity since the 90's.  I don't recall eating or drinking anything out of the ordinary. I also don't have any allergies to foods or medications (at least not that I know of). Therefore, the only thing that made sense to me was a 'delayed' response to the Moderna booster. Right now I'm taking Zyrtec daily and it helps with the itching. It's starting to subside and I hope it goes away in a few days or weeks.
Patient found to be COVID-19 positive on 8.24.21 - went to ED (not admitted); fully vaccinated  Later hospitalized (9.21.21);  found to be COVID-19 positive at DC (9.26.21);  Fully vaccinated Admission Date: 9/21/2021 Discharge Date: 09/26/2021 Presenting Problem: Unstable angina (HCC) DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: PT is a 82 y.o. female with history of hypertension, dyslipidemia, obstructive sleep apnea, obesity, chronic kidney disease stage 3 and coronary artery disease with previous PCI to her circumflex x2 in 2006 and her LAD in 2010. She presented 9/21 with complaints of posterior left shoulder pain which was reminiscent of prior angina. She ruled out for ACS. She was risk stratified with Lexiscan nuclear stress test that was abnormal with peri-infarct ischemia along with distal inferior lateral wall. LV EF calculated at 52%.   Coronary angiography revealed stable CAD, no angiographic culprit to account for presentation symptoms. She was started on amlodipine for additional antianginal therapy. PT/OT evaluated and recommended SAR for ongoing care. Of note she was incidentally COVID-19 + on day of discharge but was not symptomatic.
Severe muscle spasms in which her legs from her waist down was jerking upward. It would lift off the bed or off the floor. She couldn't walk. The jerking was every two minutes. Uncontrolled twitching or muscle spasms. It lasted from 05:00 am until about 11:00 pm. We took her to the ER. She also had a migraine and then her left foot where she has the nerve pain was inflamed. They gave her the Taradol and that and the calcium seemed to calm it down. They followed up with the neurologist at the hospital while she was there as the doctor in ER said she hadn't seen anything like that before..  We were sent home at midnight and by the following morning, it was gone. Doctor's notes: lower body twitching/lower extremity twitching. No treatment at home after the ER visit.
Mom reported site of Varicella is blister. Bumps at site, red and raised. Size of golfball. Mom giving BENADRYL. 5/9 Not as red. Does have knot, more red spots, no blisters. Informed use cool compresses.
2 1/2 hrs after vaccine given in (L) deltoid pt noted 2 raised "blister-like" bumps on (L) upper arm about 4 inches away from injection site. Pt given Benadryl po and ice pack.
Developed acute eczema around a previous area of injury - due to ligament laceration. Did not have any similar skin irritations prior to incident or after incident; only developed shortly after 2 doses of Moderna vaccine for COVID-19.
his is a spontaneous report received from a non-contactable reporter NT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete but unknown manufacturer), for COVID-19 immunization. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "headaches".  Additional information: The reporter said he talked to 200 people who have a headaches from that booster shot.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
1 week after vaccine was administered, child had low grade fever. 10 days after vaccine was administered, child had red spots (over 200) on abdomen/trunk, back, and face. Spots never did blister or scab. Spots disappeared after 4 days. Child was irritable while spots were present.
Received the vaccine on 12/23/2020, felt great after, no allergy reaction, just a sore arm at the injection site. During the night of 12/24/2020, started having my lymph node in my left armpit swelling up, and feeling very tired. Felt like I was breaking a slight fever. Took ibuprofen in the morning, no fever (97.6), still having lymph node swollen and feeling extremely tired. Otherwise no other side effect so far. Will continue to self monitor and treat symptoms with ibuprofen.  When i received the flu vaccine and tDap vaccine in my left arm, same situation, lymph node in my left arm pit started swelling within 24 hrs, and went away after 3 days. I'm expecting the same with this one.
she was going to pass out; started feeling bad; completely cramping, laid down on the floor until the ENT; chills; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of LOSS OF CONSCIOUSNESS (she was going to pass out) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Acid reflux (oesophageal), Rotator cuff injury and Thyroid disorder. Concomitant products included PANTOPRAZOLE for Acid reflux (oesophageal), LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder, ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced LOSS OF CONSCIOUSNESS (she was going to pass out) (seriousness criterion medically significant), FEELING ABNORMAL (started feeling bad), MUSCLE SPASMS (completely cramping, laid down on the floor until the ENT) and CHILLS (chills). On 25-Mar-2021, LOSS OF CONSCIOUSNESS (she was going to pass out) had resolved. At the time of the report, FEELING ABNORMAL (started feeling bad), MUSCLE SPASMS (completely cramping, laid down on the floor until the ENT) and CHILLS (chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment products included Pantoprazole 40 mg BID (after vaccine adverse event) Concomitant products included Valsartan HCTZ 160/25 QD Patient said she was informed she might have Vasovagal response. After staying the emergency room for 6 hours all of her blood work and test came back to normal. The heartburn did not change at all. Patient's new GI doctor suggested that she might be experiencing from inflammatory response from the vaccine and suggested to stay on Pantoprazole 40 mg and double the dose. Patient then spoke with her retired GI doctor who said that the vaccine might cause weaken her system and now its compromised. Patient said that her digestive system and quality of life has been affected after the vaccination. Consent to follow up with patient and health care professional given.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   This case was linked to MOD-2021-253202 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Right eye turned blood red/ Both my father, a family friend and another patient at same doctor's office all experienced same thing.; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received an unknown dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expiry date were not reported), via an unspecified route of administration, on an unspecified date, as dose number unknown, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced right eye turned blood red/ Both my father, a family friend and another patient at same doctor's office all experienced same thing. The reporter stated that the right eye turned blood red, no pain though. Next day the eyeball itself was swollen, especially at the interior corner of eye. Still no pain. No discharge. Eye doctor could find no indication of anything in eye. Not allergies. Left eye was fine. This occurred 2 wks past 1st vaccine. Doctor finally put her on Prednisone which helped. The reporter stated that both my father, a family friend and another patient at same doctor's office all experienced same thing. We wouldn't have attributed it to the vaccine if we hadn't been talking and realized we all had same symptoms, same time frame past vaccine for symptoms to show up and Pfizer vaccine. Adverse event resulted in physician office visit. Outcome of the event was unknown.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
This is a spontaneous report from a contactable nurse, who reported for a patient. This 3-year-old (race unknown) male patient started to receive PREVNAR 13 on 15Dec2010 at 0.5cc in his upper left thigh for routine immunization. The relevant medical history of the patient was unknown. The relevant concomitant medication included was an unknown flu vaccine on 15Dec2010 at an unknown dose and frequency. The patient started experiencing red hot swelling in the upper left thigh on an unknown date in Dec2010. The reporter mentioned that the red hot swelling was 6/6 centimeters. The relevant laboratory tests were none. The status of therapy with PREVNAR 13 was unknown at the time of the report. The therapeutic measure taken in response to the event was KEFLEX which was prescribed on 17Dec2010 at 250mg at an unknown frequency. The patient had not recovered at the time of the report. Follow-up attempts completed. No further information expected. Follow-up (08FEB2011): Follow-up attempts completed. No further information is needed.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 11Apr2022 at 17:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 56 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Diabetes" (unspecified if ongoing); "High Blood pressure" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset May2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of covid-19.  Clinical Information: Product used for COVID 19 Treatment, brand:Paxlovid,  treatment start date:25May2022, treatment Stop date:29May2022, lot number:GA3567  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Headache, body aches, upset stomach (nausea; no vomiting); flushed, low grade fever. Began 1 day post vaccination, lasted 2 days.
This case was reported by a healthcare professional and described the occurrence of injection site tenderness in a female subject of unspecified age who was vaccinated with FLULAVAL (GlaxoSmithKline). On 4 October 2010 the subject received a dose of FLULAVAL (details unknown). On either 4 or 5 October 2010, less than one week after vaccination with FLULAVAL, the subject experienced a 2-4 inch area of injection site tenderness, injection site redness and hotness at injection site. At the time of reporting the events were improved. The healthcare professional reported that she gave approximately 40 vaccinations to employees and has had 7 reports of 2-4 inch area around the injection site that was tender, red and warmer than the surrounding skin. This is case 5 of 7 (see case IDs A0885121A, A0885268A - A0885270A, A0885272A, A0885273A for the other reports). The healthcare professional also reported an additional subject who experienced different adverse events following vaccination with FLULAVAL (see case ID A0885114A for more details). Follow-up information received on 26 October 2010. It was indicated that the subject was 26 years old at the time of the events. The events began on 04 October 2010, the day on vaccination. Events resolved on 05 October 2010. It was noted that subject's weight value was 95, however, units were not provided.
swelling; redness; itching; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling), ERYTHEMA (redness) and PRURITUS (itching) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced SWELLING (swelling), ERYTHEMA (redness) and PRURITUS (itching). At the time of the report, SWELLING (swelling), ERYTHEMA (redness) and PRURITUS (itching) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.
On 5/18/2000, the pt received her 1st Lymerix. 4 1/2 hours later, she experienced flu-like symptoms, chills and fever. Treatment included Aleve. The information received on 5/23/00, reported the symptoms resolved after 2 hours.
achy; arm hurts; Headache; This is a spontaneous report from a contactable consumer or other non-health care professional (Patient's mother). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: Unknown) via an unspecified route of administration on an unspecified date as dose number unknown, single for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. Caller states she had a quick question. She forgot what the pharmacist said but her son got the shot and on unspecified date he was achy, his arm hurted and he had a headache. The caller clarified she was referring to the Pfizer BioNTech COVID-19 vaccine. She asked what her son can take, Tylenol or Aspirin. She believes the pharmacist said Tylenol, but he may have said Aspirin, she doesn't know. She doesn't want to give him Aspirin if the pharmacist said Tylenol or Tylenol if he said Aspirin. She doesn't want to give him the wrong thing. Caller declined to complete a report on behalf of her son, stated she just wanted to know if she can give him Tylenol or Aspirin. Caller made the comment she had one too, but her shot wasn't Pfizer. Her son was having the same symptoms as she did: achy, arm feels like there is a knot in it, a headache- she just felt achy. Caller declined to complete a report on behalf of herself or her son because the symptoms seem like normal, it was not anything unusual. The outcome of events was unknown.  Information about batch/ lot number has been requested.
Very sore arm at injection site from 12-36 hours after injection. Injection site still tender through 10 days after injection. Slightly elevated temperature 10-18 hours after injection 99.4° F. Muscle twinges from 12-18 hours after injection. PRIMARY CONCERN: Heightened tinnitus starting 13 days after injection. I have had mild tinnitus in both ears for about 8 years. The volume as of yesterday has approximately doubled in my right ear with new tones heard, and is about 25% louder in my left ear than before.